[Federal Register Volume 68, Number 127 (Wednesday, July 2, 2003)]
[Notices]
[Page 39577]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-16617]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2003N-0201]


Minimizing Medication Errors--Methods for Evaluating Proprietary 
Names for Their Confusion Potential; Public Meeting; Correction

AGENCY: Food and Drug Administration; HHS.

ACTION: Notice of public meeting; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of May 30, 2003 (68 FR 32529). 
The document announced a public meeting to explore current methods 
being used to evaluate proprietary drug names to reduce medication 
errors due to similarity in drug names. The document was published with 
the incorrect docket number. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Joyce A. Strong, Chief, Regulations 
Editorial Section (HF-27), Food and Drug Administration, 5600 Fishers 
Lane, Rockville, MD 20857, 301-827-7010.

SUPPLEMENTARY INFORMATION: In FR Doc. 03-13591, appearing on page 35679 
in the Federal Register of May 30, 2003, the following correction is 
made:
    1. On page 32529, in the third column, the Docket No. ``02N-0201'' 
should be corrected to read ``2003N-0201''.

    Dated: June 25, 2003.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 03-16617 Filed 7-1-03; 8:45 am]
BILLING CODE 4160-01-S